Centenial Surgical Suture Ltd (CSURGSU) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Centenial Surgical Suture Ltd on NSE and BSE, with an AI summary of each filing.
please find attached
Others (Uncategorized) · 26 Oct 2026, 5:09 pm
Centenial Surgical Suture Requests Investigation Into Alleged Scrip Price Manipulation Centenial Surgical Suture Ltd. has formally requested BSE and SEBI to urgently investigate abnormal price volatility and suspected manipulative trades in its scrip (531308 / 531380). On 26th Oct'26, trades ranged from Rs.66.60 to Rs.71.25 on negligible volumes (2 to 120 shares), following sharp price movements unsupported by corporate announcements or material business changes. Management alleged coordinated, circular retail-order buying designed to manipulate prices and trigger circuits, while confirming that the company, its promoters, and directors have no involvement in these illicit activities.
please find attached
Others (Uncategorized) · 21 Oct 2026, 8:02 pm
Centenial Surgical Suture Requests Regulatory Probe into Suspected Stock Price Manipulation Centenial Surgical Suture Ltd. (BSE: 531308) has formally requested BSE and SEBI to investigate suspected price manipulation and unusual trading activity in its equity shares. In a letter dated 21st Oct'26, the company highlighted an abnormal price drop unsupported by corporate announcements or material business changes, pointing to frequent low-volume transactions, such as a single share trading at Rs.71.25. The company alleged coordinated syndicate operations, circular trading, and misuse of circuit limits, while confirming that promoters and management have no involvement in the activity.
please find attached
Others (Uncategorized) · 19 Oct 2026, 8:16 pm
Centenial Surgical Suture Flags Stock Manipulation and Abnormal Price Fall to BSE Centenial Surgical Suture Ltd. (Scrip: 531308) has formally requested BSE and SEBI to urgently investigate suspected price rigging, circular trading, and artificial trade manipulation in its shares. On 19th Oct'26, the company observed only one share trading at Rs.71.25 despite an abnormal price drop unsupported by corporate announcements or operational changes. The management noted suspicious low-volume orders and synchronized trading across various brokers to evade surveillance, clarifying that promoters, directors, and associates have no role in these activities.
Please find attached
Change in Management · 06 Oct 2026, 1:29 am
Centenial Surgical Suture Executive Director Anuradha Kashikar Resigns Centenial Surgical Suture Ltd. announced the resignation of Anuradha Kashikar (DIN: 00804831) from her position as Executive Director and Key Managerial Personnel, effective from the closure of business hours on 5th Oct'26. The resignation is attributed to personal reasons, with Kashikar confirming there are no other material reasons behind her departure. Additionally, she holds no directorships in any other listed entities.
Scrutinizer Report
Annual General Meeting · 29 Sept 2026, 1:23 am
Centeniel Surgical Suture AGM Voting Results Centenial Surgical Suture Ltd. announced the voting results and Scrutinizer’s Report for its 31st Annual General Meeting held on 28th Sep'26. Shareholders approved all three ordinary resolutions with 99.99% majority votes via remote e-voting and e-voting during the AGM. Key approved resolutions include the adoption of audited financial statements for the year ended 31st Mar'26, along with the retirement by rotation and re-appointment of Ms. Anuradha Kashikar as Executive Director. For Resolution 3, 698,500 votes belonging to the interested director were deemed invalid.
Proceeding of 31st Annual General Meeting .
Annual General Meeting · 29 Sept 2026, 1:14 am
please find attched
Change in Management · 12 Sept 2026, 5:21 am
Centenial Surgical Suture Appoints Sapna Mhatre as CFO Following Anuradha Kashikar's Resignation Centenial Surgical Suture Ltd. announced the resignation of Chief Financial Officer and Key Managerial Personnel Ms. Anuradha Kashikar due to personal reasons, effective 14th Aug'26. The Board has appointed Ms. Sapna Mhatre as the new CFO and KMP, effective the same date. Mhatre, formerly the Chief Administrative Officer with the company since Sep'01, holds a B.Com. and DFM, and is not related to any Director.
Pursuant to Regulation 34 of the SEBI (LODR) Regulations, 2015 as amended, we herewith submit the Annual Report of the Company for the financial year 2025-2026 along with the Notice convening ....
Others (Uncategorized) · 02 Sept 2026, 1:36 am
please find attached
Annual General Meeting · 02 Sept 2026, 1:26 am
please find attached
Annual General Meeting · 02 Sept 2026, 1:20 am
as per attachment
Others (Uncategorized) · 26 Aug 2026, 10:07 pm
Centenial Surgical Reports Abnormal Price Rise, Suspects Market Manipulation Centenial Surgical Suture Ltd. (Scrip: 531308) has alerted BSE about abnormal price rises and unusual trading activity, suspecting manipulation. The company highlights multiple instances of single-share trades causing significant price increases, such as a 4.64% rise to Rs.97.49 on Aug 26, '26, and a 4.99% rise to Rs.98.69 on Aug 21, '26. Centenial states these price movements are unsupported by any corporate announcements and requests an urgent investigation by BSE and SEBI into potential unethical trading and price rigging.
as per attachment
Annual General Meeting · 15 Aug 2026, 12:58 am
Centenial Surgical Suture Sets AGM and E-Voting Dates Centenial Surgical Suture Ltd. will hold its 31st AGM via video conferencing on 28 Sep'26 at 2:00 p.m. (IST). The company has fixed 21 Sep'26 as the cut-off date to determine member eligibility for remote e-voting and e-voting at the AGM. The e-voting period opens on 24 Sep'26 at 9:00 a.m. and closes on 27 Sep'26 at 5:00 p.m. This announcement is pursuant to Regulation 44 of SEBI (LODR) Regulations, 2015.
as per attachment
Others (Uncategorized) · 15 Aug 2026, 12:28 am
Centennial Surgical Suture Approves Executive Director Re-appointment The Board of Directors approved the re-appointment of Ms. Anuradha Kashikar as Executive Director on 14 Aug'26, subject to shareholder approval. The new three-year term is effective from 01 Apr'27 to 31 Mar'30. Ms. Kashikar, who has served as ED since 27 Mar'15, will continue her role with nil remuneration for the fiscal year 2025-2026. Her current term expires on 31 Mar'27. She is the spouse of the Managing Director, Vijay Majrekar. The Board cited her experience as beneficial for the company.
as per attachment
Change in Management · 15 Aug 2026, 12:25 am
Centenial Surgical Appoints New CFO Amid Key Leadership Change Centenial Surgical Suture Ltd. announced a key management change effective 14 Aug'26. Ms. Anuradha Kashikar has resigned as Chief Financial Officer for personal reasons, with no other material reasons cited. Ms. Kashikar is the spouse of the Managing Director, Vijay Majrekar. Concurrently, Ms. Sapna Mhatre, previously Chief Administrative Officer and an employee since Sep'01, has been appointed as the new CFO. Ms. Mhatre holds a B.Com and a Diploma in Financial Management and is not related to any company directors.
AS PER ATTACHMENT
Change in Auditor · 15 Aug 2026, 12:18 am
Centenial Surgical Appoints Utsav Shah & Associates as Internal Auditor Centenial Surgical Suture Ltd. (Scrip: 531380) appointed M/s. Utsav Shah & Associates, Chartered Accountants (FRN 140896W), as its internal auditor for FY26-27. The appointment was made during the board meeting on 14 Aug'26 to comply with the Companies Act 2013 and SEBI (LODR) Regulations. The appointed firm, led by Shri Utsav Shah, has approximately a decade of experience in auditing and assurance. This change ensures regulatory adherence for the upcoming financial year.
AS PER ATTACHED
Financial Result · 14 Aug 2026, 11:58 pm
Centenial Surgical Suture Reports Profitable Q1 FY27, Reversing Prior Losses Centenial Surgical Suture posted a profit of ₹73.51 lakh for Q1 FY27, a significant turnaround from a loss of ₹3.91 lakh in Q1 FY26 and a loss of ₹231.35 lakh in Q4 FY26. Total revenue for the quarter ended Jun'26 grew 18.7% YoY to ₹1,535.41 lakh. The company's performance was also a sharp improvement sequentially, with revenue up 21.4% QoQ from ₹1,265.08 lakh. Basic EPS stood at ₹2.01 for the quarter, compared to ₹(0.11) in the prior-year period.
AS PER ATTACHMENT
Outcome · 14 Aug 2026, 11:50 pm
Centenial Surgical Suture: CFO Transition and Key Board Approvals Centenial Surgical Suture approved Q1'27 financials for the quarter ending 30 Jun'26. The Board accepted the resignation of Ms. Anuradha Kashikar as CFO, effective 14 Aug'26, while re-appointing her as Executive Director for three years from 01 Apr'27 to 31 Mar'30, pending shareholder approval. Ms. Sapna Mhatre was appointed as the new CFO, effective 14 Aug'26. The 31st AGM is scheduled for 28 Sep'26. M/s. Utsav Shah & Associates were appointed as Internal Auditors for FY27.
Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. To approve Standalone ....
Intimation · 14 Aug 2026, 5:30 am
Intimation under Reg 30 SEBI (LODR) Regulations 2015 - Retirement of Senior Management Personnel (SMP)
Change in Management · 24 Jun 2026, 10:31 pm
Centenial Surgical Suture Announces Retirement of President - Production Centenial Surgical Suture Ltd. (BSE: 531380) announced that Mr. Sanjay Sohani, President - Production and a Senior Management Personnel, has retired from the company. The retirement is effective from the close of business hours on 20th Jun'26. Consequently, Mr. Sohani ceases to be a Senior Management Personnel from the aforesaid date. This intimation was filed under Regulation 30 of the SEBI (LODR) Regulations, 2015. The reason cited for the change in key personnel is retirement.
PFA
Financial Result · 31 May 2026, 12:28 am
Centenial Surgical Suture Reports Wider Loss in Q4 and Full-Year FY26 For the quarter ended 31 Mar'26, Centenial Surgical Suture reported a net loss of Rs. 231.35 lakh, widening from a Rs. 118.35 lakh loss YoY. Revenue from operations declined 5.4% YoY to Rs. 1,258.49 lakh. For the full year FY26, the company posted a net loss of Rs. 220.46 lakh, compared to a Rs. 146.37 lakh loss in FY25. Full-year revenue saw a marginal increase of 0.6% YoY to Rs. 5,384.02 lakh. Basic EPS for FY26 stood at Rs. (6.04) versus Rs. (4.01) in the prior year.
PFA
Outcome · 31 May 2026, 12:22 am
Centenial Surgical Suture Board Approves FY26 Financials The Board of Directors for Centenial Surgical Suture Ltd. (BSE: 531380) met on 30 May'26 and approved the Standalone Audited Financial Results for the quarter and year ended 31 Mar'26. The company also noted that its Statutory Auditors have issued an unmodified opinion on the annual financial statements. Additionally, the Board disclosed Related Party Transactions as per regulatory requirements. The meeting concluded on the same day.
Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1) To approve Standalone ....
Intimation · 30 May 2026, 5:30 am
Centenial Surgical Suture Board Meeting to Approve Financial Results Centenial Surgical Suture Ltd. (Scrip Code: 531380) will hold a Board of Directors meeting on 30 May'26. The primary agenda is to consider and approve the Standalone Audited Financial Results and the Auditors Report for the quarter and financial year ended 31 Mar'26. This action is pursuant to Regulation 29 and 33 of SEBI (LODR) Regulations, 2015. The approved results will be disclosed post-meeting.
PFA
Others (Uncategorized) · 11 May 2026, 7:26 pm
Centenial Surgical Suture Flags Potential Stock Price Manipulation to BSE Centenial Surgical Suture Ltd. has formally requested BSE and SEBI to investigate a significant, abnormal rise in its share price (Scrip no. 531380), suspecting unethical and manipulative trading. In a letter dated May 11, '26, the company states the price movement is unsupported by any corporate announcements or fundamental changes. It alleges possible price rigging through thin-volume, synchronized trades by a syndicate of common entities, often in small lots of 1-5 shares, to avoid surveillance. The company denies any involvement from promoters or management.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 30 Apr 2026, 2:18 am
PFA
Others (Uncategorized) · 17 Mar 2026, 10:03 pm
Centenial Surgical Flags Potential Share Price Manipulation to Exchange Centenial Surgical Suture Ltd. (Scrip: 531380) has alerted the BSE to unusual and significant price movement in its shares, alleging potential price rigging. In a letter dated 17 Mar'26, the company states the price volatility is unsupported by any corporate announcements or fundamental business changes. Management highlights thin trading volumes, suspicious synchronized trading, and repeated small-lot purchases by various entities as evidence of a pre-planned scheme. Centenial has requested an urgent and complete investigation by the exchange into these manipulative trading activities.